A Cognitive Behavioral Therapy-Based Text Messaging Intervention for Methamphetamine Dependence
1 other identifier
interventional
25
1 country
1
Brief Summary
This Phase I, randomized, 22-day crossover study seeks to improve treatment outcomes for methamphetamine-dependent subjects by developing a cognitive behavioral therapy (CBT)- based short message service (SMS) text messaging intervention as an adjunct to CBT group therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Apr 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 5, 2012
CompletedFirst Posted
Study publicly available on registry
April 16, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedJuly 10, 2013
July 1, 2013
1.2 years
April 5, 2012
July 8, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of the intervention in methamphetamine users
Subjects will respond to \>50% of text messaging inquiries (about the usefulness of the messages, maximum degree of craving, and whether they have used that day).
22 days
Secondary Outcomes (1)
Acceptability of the intervention in methamphetamine users
22 days
Study Arms (2)
CBT-based text messages - Week 1 or 3
EXPERIMENTALOne week CBT-based text messages followed by a 1-week washout period (Week 2)
Placebo text messages - Week 3 or 1
PLACEBO COMPARATORInterventions
Messages sent at random intervals 4 times per day during weeks 1 and 3. Subjects can also request messages if they are craving methamphetamine
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
New Leaf Treatment Center
Lafayette, California, 94549, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
S. Alex Stalcup, MD
New Leaf Treatment Center
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2012
First Posted
April 16, 2012
Study Start
April 1, 2012
Primary Completion
July 1, 2013
Study Completion
July 1, 2013
Last Updated
July 10, 2013
Record last verified: 2013-07